Lp(a) Glycoprotein Phenotypes. Inheritance and Relation to Lp(a)-lipoprotein Concentrations in Plasma

Overview

Journal J Clin Invest

Specialty General Medicine

Date 1987 Aug 1

PMID 2956279

Citations 134

Authors

G Utermann

H J Menzel

H G Kraft

H C Duba

H G Kemmler

C Seitz

Affiliations

Soon will be listed here.

Abstract

The Lp(a) lipoprotein represents a quantitative genetic trait. It contains two different polypeptide chains, the Lp(a) glycoprotein and apo B-100. We have demonstrated the Lp(a) glycoprotein directly in human sera by sodium dodecyl sulfate-gel electrophoresis under reducing conditions after immunoblotting using anti-Lp(a) serum and have observed inter- and intraindividual size heterogeneity of the glycoprotein with apparent molecular weights ranging from approximately 400,000-700,000 D. According to their relative mobilities compared with apo B-100 Lp(a) patterns were categorized into phenotypes F (faster than apo B-100), B (similar to apo B-100), S1, S2, S3, and S4 (all slower than apo B-100), and into the respective double-band phenotypes. Results from neuraminidase treatment of isolated Lp(a) glycoprotein indicate that the phenotypic differences do not reside in the sialic acid moiety of the glycoprotein. Family studies are compatible with the concept that Lp(a) glycoprotein phenotypes are controlled by a series of autosomal alleles (Lp[a]F, Lp[a]B, Lp[a]S1, Lp[a]S2, Lp[a]S3, Lp[a]S4, and Lp[a]0) at a single locus. Comparison of Lp(a) plasma concentrations in different phenotypes revealed a highly significant association of phenotype with concentration. Phenotypes B, S1, and S2 are associated with high and phenotypes S3 and S4 with low Lp(a) concentrations. This suggests that the same gene locus is involved in determining Lp(a) glycoprotein phenotypes and Lp(a) lipoprotein concentrations in plasma and is the first indication for structural differences underlying the quantitative genetic Lp(a)-trait.

Citing Articles

Lipoprotein(a) Response to Dietary Saturated Fat Reduction: Relationship to Apolipoprotein(a) Size Polymorphism in African Americans.

Law H, Myagmarsuren M, Bang H, Zhang W, Lefevre M, Berglund L Nutrients. 2025; 17(3).

PMID: 39940285 PMC: 11820444. DOI: 10.3390/nu17030426.

Lipoprotein(a) and cardiovascular disease.

Boffa M, Koschinsky M Biochem J. 2024; 481(19):1277-1296.

PMID: 39302109 PMC: 11555715. DOI: 10.1042/BCJ20240037.

Causal effect of lipoprotein(a) level on chronic kidney disease of European ancestry: a two-sample Mendelian randomization study.

Zhu Y, Chen S, Chen Z, Wang Y, Fu G, Zhang W Ren Fail. 2024; 46(2):2383727.

PMID: 39082753 PMC: 11293262. DOI: 10.1080/0886022X.2024.2383727.

Functional interrogation of cellular Lp(a) uptake by genome-scale CRISPR screening.

Khan T, Bragazzi Cunha J, Raut C, Burroughs M, Goonewardena S, Smrcka A bioRxiv. 2024; .

PMID: 38766193 PMC: 11100788. DOI: 10.1101/2024.05.11.593568.

The ins and outs of lipoprotein(a) assay methods.

Heydari M, Rezayi M, Ruscica M, Jpamialahamdi T, Johnston T, Sahebkar A Arch Med Sci Atheroscler Dis. 2024; 8:e128-e139.

PMID: 38283929 PMC: 10811544. DOI: 10.5114/amsad/176653.

References

Redgrave T, Roberts D, West C . Separation of plasma lipoproteins by density-gradient ultracentrifugation. Anal Biochem. 1975; 65(1-2):42-9. DOI: 10.1016/0003-2697(75)90488-1. View

Fless G, Rolih C, Scanu A . Heterogeneity of human plasma lipoprotein (a). Isolation and characterization of the lipoprotein subspecies and their apoproteins. J Biol Chem. 1984; 259(18):11470-8. View

Krempler F, Kostner G, Roscher A, Haslauer F, Bolzano K, SANDHOFER F . Studies on the role of specific cell surface receptors in the removal of lipoprotein (a) in man. J Clin Invest. 1983; 71(5):1431-41. PMC: 437007. DOI: 10.1172/jci110896. View

Harvie N, Schultz J . Studies of Lp-lipoprotein as a quantitative genetic trait. Proc Natl Acad Sci U S A. 1970; 66(1):99-103. PMC: 286093. DOI: 10.1073/pnas.66.1.99. View

Moeremans M, Daneels G, Van Dijck A, Langanger G, de Mey J . Sensitive visualization of antigen-antibody reactions in dot and blot immune overlay assays with immunogold and immunogold/silver staining. J Immunol Methods. 1984; 74(2):353-60. DOI: 10.1016/0022-1759(84)90303-x. View

Lin N, Langenberg W . Immunohistochemical localization of barley stripe mosaic virions in infected wheat cells. J Ultrastruct Res. 1983; 84(1):16-23. DOI: 10.1016/s0022-5320(83)90082-5. View

Ehnholm C, Garoff H, Simons K, Aro H . Purification and quantitation of the human plasma lipoprotein carrying the Lp(a) antigen. Biochim Biophys Acta. 1971; 236(2):431-9. DOI: 10.1016/0005-2795(71)90223-6. View

Bersot T, Innerarity T, Pitas R, Rall Jr S, Weisgraber K, Mahley R . Fat feeding in humans induces lipoproteins of density less than 1.006 that are enriched in apolipoprotein [a] and that cause lipid accumulation in macrophages. J Clin Invest. 1986; 77(2):622-30. PMC: 423398. DOI: 10.1172/JCI112345. View

Ehnholm C, Garoff H, Renkonen O, Simons K . Protein and carbohydrate composition of Lp(a)lipoprotein from human plasma. Biochemistry. 1972; 11(17):3229-32. DOI: 10.1021/bi00767a015. View

10.

Utermann G, Weber W . Protein composition of Lp(a) lipoprotein from human plasma. FEBS Lett. 1983; 154(2):357-61. DOI: 10.1016/0014-5793(83)80182-3. View

11.

Gaubatz J, Heideman C, Gotto Jr A, Morrisett J, Dahlen G . Human plasma lipoprotein [a]. Structural properties. J Biol Chem. 1983; 258(7):4582-9. View

12.

Wiegandt H, Lipp K, WENDT G . [Identification of a lipoprotein with antigenic activity in the Lp-system]. Hoppe Seylers Z Physiol Chem. 1968; 349(4):489-94. View

13.

Armstrong V, Walli A, Seidel D . Isolation, characterization, and uptake in human fibroblasts of an apo(a)-free lipoprotein obtained on reduction of lipoprotein(a). J Lipid Res. 1985; 26(11):1314-23. View

14.

Harvie N, Schultz J . Studies on the heterogeneity of human serum Lp lipoproteins and on the occurrence of double Lp lipoprotein variants. Biochem Genet. 1973; 9(3):235-45. DOI: 10.1007/BF00485737. View

15.

Towbin H, Staehelin T, Gordon J . Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc Natl Acad Sci U S A. 1979; 76(9):4350-4. PMC: 411572. DOI: 10.1073/pnas.76.9.4350. View

16.

Albers J, Hazzard W . Immunochemical quantification of human plasma Lp(a) lipoprotein. Lipids. 1974; 9(1):15-26. DOI: 10.1007/BF02533209. View

17.

Berg K . A NEW SERUM TYPE SYSTEM IN MAN--THE LP SYSTEM. Acta Pathol Microbiol Scand. 1963; 59:369-82. DOI: 10.1111/j.1699-0463.1963.tb01808.x. View

18.

Hunter W, GREENWOOD F . Preparation of iodine-131 labelled human growth hormone of high specific activity. Nature. 1962; 194:495-6. DOI: 10.1038/194495a0. View

19.

Berg K . Lp(a) lipoprotein enters cultured fibroblasts independently of the plasma membrane low density lipoprotein receptor. Clin Genet. 1981; 20(5):352-62. DOI: 10.1111/j.1399-0004.1981.tb01047.x. View

20.

Krempler F, Kostner G, Bolzano K, SANDHOFER F . Turnover of lipoprotein (a) in man. J Clin Invest. 1980; 65(6):1483-90. PMC: 371487. DOI: 10.1172/JCI109813. View